2025-02-01 2026-01-31 false No description of principal activity Capium Accounts Production 1.1 11759213 2025-02-01 2026-01-31 11759213 bus:AbridgedAccounts 2025-02-01 2026-01-31 11759213 bus:FRS102 2025-02-01 2026-01-31 11759213 bus:AuditExemptWithAccountantsReport 2025-02-01 2026-01-31 11759213 bus:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 11759213 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 11759213 2025-02-01 2026-01-31 11759213 2026-01-31 11759213 bus:RegisteredOffice 2025-02-01 2026-01-31 11759213 core:WithinOneYear 2026-01-31 11759213 core:AfterOneYear 2026-01-31 11759213 1 2025-02-01 2026-01-31 11759213 bus:Director1 2025-02-01 2026-01-31 11759213 bus:Director1 2026-01-31 11759213 bus:Director1 2024-02-01 2025-01-31 11759213 2024-02-01 11759213 bus:LeadAgentIfApplicable 2025-02-01 2026-01-31 11759213 2024-02-01 2025-01-31 11759213 2025-01-31 11759213 core:WithinOneYear 2025-01-31 11759213 core:AfterOneYear 2025-01-31 11759213 bus:EntityAccountantsOrAuditors 2024-02-01 2025-01-31 11759213 bus:OrdinaryShareClass1 2025-02-01 2026-01-31 11759213 bus:OrdinaryShareClass1 2026-01-31 11759213 bus:OrdinaryShareClass1 2024-02-01 2025-01-31 11759213 bus:OrdinaryShareClass1 2025-01-31 11759213 core:CostValuation core:Non-currentFinancialInstruments 2026-01-31 11759213 core:CostValuation core:Non-currentFinancialInstruments 2025-01-31 11759213 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-01-31 11759213 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 11759213 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 11759213 core:Non-currentFinancialInstruments 2026-01-31 11759213 core:Non-currentFinancialInstruments 2025-01-31 11759213 core:ShareCapital 2026-01-31 11759213 core:ShareCapital 2025-01-31 11759213 core:RetainedEarningsAccumulatedLosses 2026-01-31 11759213 core:RetainedEarningsAccumulatedLosses 2025-01-31 11759213 dpl:Item1 2025-02-01 11759213 dpl:Item1 2026-01-31 11759213 dpl:Item1 2024-02-01 11759213 dpl:Item1 2025-01-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 11759213
England and Wales
MEDCONTACT LTD
Abridged Accounts
Period of accounts Start date: 01 February 2025 End date: 31 January 2026

MEDCONTACT LTD Contents Page For the year ended 31 January 2026
Statement of financial position | 1
Notes to the financial statements | 2

MEDCONTACT LTD Statement of Financial Position As at 31 January 2026
| Notes | 2026 £ |  | 2025 £
--- | --- | --- | --- | ---
Current assets |  |  |
Debtors |  | 0 |  | 100
Cash at bank and in hand |  | 0 |  | 650
|  | 0 |  | 750
Creditors: amount falling due within one year |  | (736) |  | (113)
Net current assets |  | (736) |  | 637
Total assets less current liabilities |  | (736) |  | 637
Net assets |  | (736) |  | 637
Capital and reserves |  |  |
Called up share capital | 3 | 100 |  | 100
Profit and loss account |  | (836) |  | 537
Shareholders' funds |  | (736) |  | 637
For the year ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the director on 26 February 2026 and were signed by:
------------------------------- Tamar Khachapuridze Director
1

MEDCONTACT LTD Notes to the Abridged Financial Statements For the year ended 31 January 2026
General Information MEDCONTACT LTD is a private company, limited by shares, registered in England and Wales, registration number 11759213, registration address 85 Great Portland Street, London, W1W 7LT. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company.
2. | Average number of employees Average number of employees during the year was 1 (2025 : 1).
3. | Share Capital
Allotted, called up and fully paid | 2026 £ |  | 2025 £
--- | --- | --- | ---
100 Class A shares of £1.00 each | 100 |  | 100
| 100 |  | 100
2